3.71MMarket Cap-0.45P/E (TTM)
0.000High0.000Low0Volume0.000Open0.765Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)4.85MShares3.59052wk High3.24P/B667.56KFloat Cap0.66752wk Low--Dividend TTM872.63KShs Float1385.000Historical High--Div YieldTTM0.00%Amplitude0.667Historical Low--Avg Price1Lot Size
Genetic Technologies Stock Forum
Notice of Delisting from Nasdaq.Melbourne Australia, 13 December, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENE) (“Genetic Technologies” or the “Company”) advices that the Company has received a Delisting Notice from Nasdaq Stock Market LLC (“Nasdaq”)relating, amo...
*************************************
REVERSE...
Melbourne Australia, December 12, 2024: Genetic Technologies Limited (Administrators Appointed) (ASX: GTG; NASDAQ: GENE) (“Genetic Technologies” or the “Company”) previously announced on November 20, 2024 that Ross Blakeley and Paul Harlond of FTI Consulting had been appointed as Joint and Several Voluntary Administrators (“Administrators”) pursuant to section 436A...
MT Newswires·
Genetic Technologies (ASX:GTG) launched the geneType Risk Assessment portfolio on its EasyDNA platform, according to a Thursday filing with the Australian Securities Exchange.
The availability of geneType on EasyDNA's consumer platform is expected to accelerate global access, potentially reaching 42 countries and generating annual revenues of AU$7.5 million, the filing sa...
NEWS
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
NEWS
Genetic Technologies Announces $2 Million Registered Direct Offering
3 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
No comment yet